CVS Caremark Corporation (NYSE:CVS) | Insurance Ups and Downs for Diabetes Drugs in 2014

[at Motley Fool] – Managed care titans CVS Caremark and Express Scripts are undertaking major changes to their preferred drug formularies that may significantly impact a number of well-known diabetes medications and . . . → Read More: CVS Caremark Corporation (NYSE:CVS) | Insurance Ups and Downs for Diabetes Drugs in 2014 Similar posts: Company Update: CVS Caremark Corporation (NYSE:CVS) – CVS expects earnings to rise in 2014, lifts dividend Company Update: Bristol-Myers Squibb Company (NYSE:BMY) – FDA panel backs Bristol diabetes drug after prior rejection Pfizer 3rd-qtr profit beats estimates; oncology drugs shine – Pfizer Inc. (NYSE:PFE)